Source:http://linkedlifedata.com/resource/pubmed/id/18620381
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
2008-8-7
|
pubmed:abstractText |
A series of novel indoline derivatives with an ionizable moiety were synthesized to find a bioavailable acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor with antiperoxidative activity. [7-(2,2-Dimethylpropanamido)-4,6-dimethyl-1-octylindolin-5-yl]acetic acid hemisulfate (2, pactimibe sulfate) with low lipophilicity and high water solubility showed good oral absorption and inhibitory activity against foam cell formation in THP-1 cells exposed to acetyl-LDL after differentiation (IC50: 0.3 microM) and an antiperoxidative effect in LDL of hypercholesterolemic rabbits (IC50: 1.0 microM). 2 inhibited macrophage, hepatic, and intestinal ACAT activity (IC50: 1.9, 0.7, and 0.7 microM, respectively). Maximal plasma concentration after oral administration of 2 at 10 mg/kg was 0.9 microg/mL in rats, 3.0 microg/mL in rabbits, and 11.2 microg/mL in dogs. Repeated administration of 2 lowered plasma LDL/VLDL cholesterol in hypercholesterolemic rabbits at 1 mg/kg/day, rats and dogs at 3 mg/kg/day, and in normocholesterolemic hamsters at 3 mg/kg/day. 2 is a promising candidate for antihyperlipidemic and antiatherosclerotic drugs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Carboxylic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Sterol O-Acyltransferase,
http://linkedlifedata.com/resource/pubmed/chemical/indoline
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1520-4804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
14
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4823-33
|
pubmed:meshHeading |
pubmed-meshheading:18620381-Animals,
pubmed-meshheading:18620381-Anticholesteremic Agents,
pubmed-meshheading:18620381-Carboxylic Acids,
pubmed-meshheading:18620381-Cell Line,
pubmed-meshheading:18620381-Cholesterol,
pubmed-meshheading:18620381-Enzyme Inhibitors,
pubmed-meshheading:18620381-Humans,
pubmed-meshheading:18620381-Indoles,
pubmed-meshheading:18620381-Lipid Peroxidation,
pubmed-meshheading:18620381-Male,
pubmed-meshheading:18620381-Molecular Structure,
pubmed-meshheading:18620381-Sterol O-Acyltransferase
|
pubmed:year |
2008
|
pubmed:articleTitle |
Novel indoline-based acyl-CoA:cholesterol acyltransferase inhibitor with antiperoxidative activity: improvement of physicochemical properties and biological activities by introduction of carboxylic acid.
|
pubmed:affiliation |
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd, Kyoto, Japan.
|
pubmed:publicationType |
Journal Article
|